Ascendis Pharma (ASND) PT Raised to $132 at Canaccord Genuity

March 4, 2019 2:47 PM

Canaccord Genuity analyst Michelle Gibson raised the price target on Ascendis Pharma (NASDAQ: ASND) to $132.00 (from $84.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found